2025 second_quarter Filing
RRLobbying Activities
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to pharmaceutical supply chain and health appropriations; Issues related to Medicare Part D policies, including non-interference and rebate policy issues; Issues related to women's health; Issues related to oncology; Issues related to ophthalmology.
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to pharmaceutical supply chain and health appropriations; Issues related to Medicare Part D policies, including non-interference and rebate policy issues; Issues related to women's health; Issues related to oncology; Issues related to ophthalmology.